Can MRI be used to determine pathological complete response following neo-adjuvant chemotherapy for breast cancer?

被引：0
|
作者：
Sharma, N. [1 ]
Dave, R. [1 ]
Millican-Slater, R. [1 ]
Dodwell, D. [1 ]
Horgan, K. [1 ]
机构：
[1] Leeds Teaching Hosp NHS Trust, Breast Unit, Level 1 Chancellor Wing, Leeds, W Yorkshire, England
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P4-02-09
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-02-09
引用
收藏
页数：2
相关论文
共 50 条
  • [1] FACTORS ASSOCIATED WITH A COMPLETE PATHOLOGICAL RESPONSE FOLLOWING NEO-ADJUVANT CHEMOTHERAPY FOR BREAST CANCER
    Pryce, Angharad
    Pang, Weehaan
    Francis, Adele
    Rea, Daniel
    [J]. EJC SUPPLEMENTS, 2010, 8 (06): : 10 - 11
  • [2] Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy
    A. Rieber
    H.-J. Brambs
    A. Gabelmann
    V. Heilmann
    R. Kreienberg
    T. Kühn
    [J]. European Radiology, 2002, 12 : 1711 - 1719
  • [3] Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy
    Rieber, A
    Brambs, HJ
    Gabelmann, A
    Heilmann, V
    Kreienberg, R
    Kühn, T
    [J]. EUROPEAN RADIOLOGY, 2002, 12 (07) : 1711 - 1719
  • [4] An analysis of response to neo-adjuvant chemotherapy in patients with locally advanced breast cancer with emphasis on pathological complete response
    Narendra, H.
    Thomas, J.
    Ray, S.
    Fernandes, D. J.
    [J]. INDIAN JOURNAL OF CANCER, 2014, 51 (04) : 587 - U233
  • [5] Predictive markers for pathological complete response after neo-adjuvant chemotherapy in triple-negative breast cancer
    Van Bockstal, Mieke R.
    Noel, Fanchon
    Guiot, Yves
    Duhoux, Francois P.
    Mazzeo, Filomena
    Van Marcke, Cedric
    Fellah, Latifa
    Ledoux, Benjamin
    Berliere, Martine
    Galant, Christine
    [J]. ANNALS OF DIAGNOSTIC PATHOLOGY, 2020, 49
  • [6] Accuracy of MRI for prediction of response to neo-adjuvant chemotherapy in triple negative breast cancer
    GJ Bansal
    D Santosh
    [J]. Cancer Imaging, 15 (Suppl 1)
  • [7] CAN ER/PR AND HER2 RECEPTOR STATUS PREDICT COMPLETE PATHOLOGICAL RESPONSE AFTER NEO-ADJUVANT CHEMOTHERAPY IN PATIENTS WITH BREAST CANCER?
    Sircar, T.
    Athwal, R.
    Brown, H.
    Dea, D.
    Hoar, F.
    [J]. EJC SUPPLEMENTS, 2010, 8 (06): : 11 - 11
  • [8] SURGICAL MANAGEMENT OF THE AXILLA IN BREAST CANCER FOLLOWING NEO-ADJUVANT CHEMOTHERAPY
    Davies, Eleri Lloyd
    [J]. ANTICANCER RESEARCH, 2015, 35 (07) : 4291 - 4291
  • [9] dNLR and TILS can be used as indicators for prognosis and efficacy evaluation of neo-adjuvant chemotherapy in breast cancer
    Wang, Xiaorui
    Zhao, Weipeng
    He, Lihong
    Wang, Shuling
    Li, Weidong
    Wang, Jing
    Tong, Zhongsheng
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (11): : 13093 - 13098
  • [10] Predictors of response to neo-adjuvant chemotherapy for locally advanced breast cancer
    Gupta, S.
    Prabhakar, S.
    Kumar, M.
    Shukla, R. C.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : S56 - S56
12345